263CS201 Phase 2 Study of BIIB104 in Subjects CIAS

• Research type

  Research Study

• Full title

  A Phase 2, Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BIIB104 in Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)

• IRAS ID

  1003226

• Contact name

  Ramin Nilforooshan

• Contact email

  Ramin.Nilforooshan@sabp.nhs.uk

• Eudract number

  2018-003825-27

• Clinicaltrials.gov Identifier

  NCT03745820

• Research summary

  Summary of Results

  The lay language summary is located here:
  https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fu2790089.ct.sendgrid.net%2Fls%2Fclick%3Fupn%3DXv3JSvJ-2B3M71ppf7N9agbU3C6at2DTeo2EYcJapm2sp9GjlfITXKeDLcclJUdxYDYNjdoPv9JX76cQXPwXqbOA-3D-3DNJ16_E1aO2-2BZlVOSJJV-2FajQqskegTd6IRomHYTi-2Fbt8SH3YJBW68BtR9pA3tQf1JHmTOmzrYLCbCOC9vHbmzOvoAf2i-2FEaXGSfCM4w2qIQCZwjIplTuwgnG8aPfe7L6NTQkZhLopeGASUYlgBzeJgA14ohpFTPI7Urvx9N9PlUW-2BYfAyWYyBpEM1TGw7Mj8dVNhozXwCHZ-2FUTWcIicHKyDtUEaA-3D-3D&data=05%7C01%7Capprovals%40hra.nhs.uk%7C1d154b76d6494aa575e608db1029dfd1%7C8e1f0acad87d4f20939e36243d574267%7C0%7C0%7C638121544268732749%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=bB0vxlPz%2BBfQrhsfksw2Q00HXI1Xj4QuU62UWsIDU4c%3D&reserved=0

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  20/SW/0086

• Date of REC Opinion

  30 Jun 2020

• REC opinion

  Further Information Favourable Opinion